Leonid Dubrovsky
- Hepatology top 1%
- Oncology top 5%
- Immunology top 10%
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Co-authors
- Josep M. LlovetMasatoshi KudoRichard S. FinnKalgi ModyAndrew X. ZhuShuichi KanekoCorina E. DutcusAbby B. Siegel
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (17 papers)Cancer Immunotherapy and Biomarkers (7 papers)CAR-T cell therapy research (6 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Leonid Dubrovsky
29 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Hepatology 858
- Oncology 828
- Immunology 399
- Pathology and Forensic Medicine 362
- Molecular Biology 294
Countries citing papers authored by Leonid Dubrovsky
This map shows the geographic impact of Leonid Dubrovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Dubrovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Dubrovsky more than expected).
Fields of papers citing papers by Leonid Dubrovsky
This network shows the impact of papers produced by Leonid Dubrovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Dubrovsky. The network helps show where Leonid Dubrovsky may publish in the future.
Co-authorship network of co-authors of Leonid Dubrovsky
This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Dubrovsky. A scholar is included among the top collaborators of Leonid Dubrovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Dubrovsky. Leonid Dubrovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 68 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 9 | |
| 9 | Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinomabreakdown → | 850 |
| 10 | 52 | |
| 11 | 68 | |
| 12 | 4 | |
| 13 | 126 | |
| 14 | 36 | |
| 15 | 6 | |
| 16 | 41 | |
| 17 | 16 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 93 |
About Leonid Dubrovsky
Leonid Dubrovsky is a scholar working on Hepatology, Oncology and Hematology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Hepatology (858 citations), Oncology (828 citations) and Pathology and Forensic Medicine (362 citations). Leonid Dubrovsky has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Josep M. Llovet, Masatoshi Kudo, Richard S. Finn, Kalgi Mody, Andrew X. Zhu, Shuichi Kaneko, Corina E. Dutcus, Abby B. Siegel, Tim Meyer and Masafumi Ikeda. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.